Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
NRXP
NRXP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NRXP News
NRx Pharmaceuticals Sets Date for 2025 Annual Meeting and Proposal Deadline
Jan 16 2026
Globenewswire
NRx Pharmaceuticals Licenses RWE from 70,000 Patients to Support NRX-100 FDA Approval
Jan 14 2026
stocktwits
NRX Pharmaceuticals' NRX-100 Receives FDA Fast Track Designation Supported by 70,000 Patient Real-World Evidence
Jan 14 2026
Globenewswire
BTIG Raises Hudson Pacific Price Target to $26
Jan 02 2026
Benzinga
NRx Pharmaceuticals Repays $5.4 Million Debt, Positions for Accelerated Growth in 2026
Dec 18 2025
Globenewswire
NRx Pharmaceuticals Repays $5.4 Million Debt, Positions for Accelerated Growth in 2026
Dec 18 2025
Newsfilter
NRx Amends NRX-101 Filing to Enhance Depression Treatment with TMS
Dec 03 2025
Globenewswire
NRx Amends NRX-101 Filing to Include TMS for Depression Treatment
Dec 03 2025
Newsfilter
NRx Receives FDA Acknowledgment for KETAFREE™ ANDA, Targeting July 2026 Approval
Dec 02 2025
Newsfilter
Post-Market Highlights: Jasper, NRx, Unicycive, Spruce, Evaxion, Solana, and Protara See Gains After Trading Hours
Dec 02 2025
NASDAQ.COM
NRx Pharmaceuticals CEO to Present at NobleCon21 on December 3rd
Dec 01 2025
Globenewswire
NRx Pharmaceuticals CEO to Present at NobleCon21 on December 3rd
Dec 01 2025
Newsfilter
VTI ETF Daily Report—November 25, 2025
Nov 25 2025
TipRanks
Daily Update on VTI ETF – November 24, 2025
Nov 24 2025
TipRanks
VTI ETF Daily Report — November 21, 2025
Nov 21 2025
TipRanks
VTI ETF Daily Update - November 20, 2025
Nov 20 2025
TipRanks
Show More News
